Secteur Lisata Therapeutics, Inc.

Actions

LSTA

US1280583022

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 27/07/2026 Varia. 5j. Varia. 1 janv.
1,440 USD -13,77% Graphique intraday de Lisata Therapeutics, Inc. -59,94% -22,58%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
-13,77%-59,94%-57,14%-55,00%-22,58%-46,47%-55,42%-93,14%-98,34% 15,21 M
-1,82%+5,03%+0,69%+18,55%+10,18%+56,71%+66,69%+201,68%+6 013,00% 57,28 Md
-0,27%+5,74%+5,48%+24,56%+37,53%+40,26%+80,17%-16,19% - 54,99 Md
-2,05%-3,31%+1,31%-22,52%-39,82%+0,75%+414,39%+338,20%+858,19% 23,18 Md
+1,97%-0,43%-0,14%-13,63%-4,32%-21,00%-13,67%-68,18% - 22,59 Md
-1,13%+4,54%+17,01%+15,33%+22,96%+22,73%-8,06%-66,96% - 20,46 Md
+1,57%+2,09%+12,10%+11,51%-5,87%+28,01%-27,56%-31,88%+57,69% 17,56 Md
-0,10%+5,57%+22,85%+7,47%+30,93%+38,63%+565,16% - - 15,67 Md
+5,29%0,00%+14,77%+113,80%+182,04%+185,09%+332,66%+1 569,75%+674,23% 14,46 Md
+0,79%-0,20%+1,90%+24,19%+27,33%+22,39%+181,58%+238,04%+545,95% 13,92 Md
+1,24%-0,40%+7,53%+7,58%-5,34%+84,74%+173,79%+545,34%+6 121,78% 12,55 Md
-0,08%+15,11%+8,42%+15,72%+28,83%+443,39%+143,68%+28,17%+1 387,48% 12,06 Md
-0,90%+11,60%+18,37%-25,08%-12,74%-33,87%+153,80%+104,56% - 11,69 Md
-0,15%+0,55%-1,91%+23,42%+26,88%+116,84%+148,83%+185,89%+715,17% 10,96 Md
-4,06%-5,10%-6,46%-40,65%-25,07%-54,29%+568,62%+71,76%+83,29% 10,9 Md
-2,05%-0,19%+13,82%+43,59%+205,37%+462,34%+600,81%-38,34%-14,86% 8,98 Md
+0,14%-0,01%+128,47%+118,76%+80,13%+170,57%+344,59%+355,95% - 8,83 Md
+1,64%+5,67%+29,67%+27,15%+16,37%+26,04%+322,89%+324,67% - 7,92 Md
+1,54%-1,25%-1,80%-6,71%+20,29%+51,52%+17,88%+145,36% - 7,89 Md
-1,55%-8,98%-19,75%-6,05%+253,03%+144,41%+186,48%-35,58% - 7,44 Md
Moyenne -0,59%-1,53%+9,76%+14,10%+41,31%+86,94%+209,87%+197,85%+1 485,78% 16,97 Md
Moyenne pondérée par Capi. -0,18%+1,88%+9,36%+16,39%+30,55%+69,56%+174,25%+180,82%+2 666,02%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action LSTA
  4. Secteur Lisata Therapeutics, Inc.